ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 30.43 Data as of Jan 30 |  -0.62 / -2.00%Today’s Change | 15.64 Today|||52-Week Range 35.01 | -4.16% Year-to-Date |
Latest ACAD News | Press Releases
| Qiagen (QGEN) Disappoints with Q4 Earnings, Revenue Miss - Analyst Blog Jan 30 / Zacks.com | VIDEO: 2 Minute Market Recap Jan 07 / StockTwits |
| VIDEO: 3 Sectors Showing Strength Jan 10 / StockTwits |
Today’s Trading
| Previous close | 31.05 |
| Today’s open | 30.88 |
| Day’s range | 30.36 - 31.73 |
| Volume | 1,130,092 |
| Average volume (3 months) | 1,278,118 |
| Market cap | $3.1B |
| Dividend yield | -- |
Data as of 4:00pm ET, 01/30/2015
Growth & Valuation
| Earnings growth (last year) | -15.79% |
| Earnings growth (this year) | -107.79% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -76.67% |
| P/E ratio | NM |
| Price/Sales | 1,870.76 |
| Price/Book | 15.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WXWuxi Pharmatech Caym... | -0.61 | -1.50% |
| MYGNMyriad Genetics Inc | -0.92 | -2.40% |
| IPXLImpax Laboratories I... | -1.02 | -2.71% |
| RCPTReceptos Inc | -2.54 | -2.25% |
Data as of 4:14pm ET, 01/30/2015
Financials
| Next reporting date | March 10, 2015 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$37.9M |
| Net profit margin | -3,314.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, CEO, Director & CAO Uli Hacksell |
Executive VP, Chief Financial & Business Officer Stephen R. Davis |
Corporate headquarters San Diego, California |
Forecasts
